Zhao C, Thompson B, Chen K, Gao F, Blouw B, Marella M, et al. The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44. Oncotarget. 2019;10:6561-6576 pubmed publisher

Lin C, Kolliopoulos C, Huang C, Tenhunen J, Heldin C, Chen Y, et al. High levels of serum hyaluronan is an early predictor of dengue warning signs and perturbs vascular integrity. EBioMedicine. 2019;48:425-441 pubmed publisher

Simonson A, Lawanprasert A, Goralski T, Keiler K, Medina S. Bioresponsive peptide-polysaccharide nanogels - A versatile delivery system to augment the utility of bioactive cargo. Nanomedicine. 2019;17:391-400 pubmed publisher

Jokela T, Oikari S, Takabe P, Rilla K, Kärnä R, Tammi M, et al. Interleukin-1β-induced Reduction of CD44 Ser-325 Phosphorylation in Human Epidermal Keratinocytes Promotes CD44 Homomeric Complexes, Binding to Ezrin, and Extended, Monocyte-adhesive Hyaluronan Coats. J Biol Chem. 2015;290:12379-93 pubmed publisher

Kim Y, Kumar S. CD44-mediated adhesion to hyaluronic acid contributes to mechanosensing and invasive motility. Mol Cancer Res. 2014;12:1416-29 pubmed publisher

Olofsson B, Porsch H, Heldin P. Knock-down of CD44 regulates endothelial cell differentiation via NF?B-mediated chemokine production. PLoS ONE. 2014;9:e90921 pubmed publisher

Qu C, Rilla K, Tammi R, Tammi M, Kroger H, Lammi M. Extensive CD44-dependent hyaluronan coats on human bone marrow-derived mesenchymal stem cells produced by hyaluronan synthases HAS1, HAS2 and HAS3. Int J Biochem Cell Biol. 2014;48:45-54 pubmed publisher

Purushothaman A, Toole B. Serglycin proteoglycan is required for multiple myeloma cell adhesion, in vivo growth, and vascularization. J Biol Chem. 2014;289:5499-509 pubmed publisher